About NorrDia

NorrDia is headquartered in Lund, Sweden, the center of the Medical and Biotech Innovation in the Nordics. It was founded 2021 by a group of business executives with a successful track record and experience from acute and chronic renal care in Gambro and Baxter.

NorrDia is in the beginning of its journey and aim to create a global position in the renal market. The NorrDia team consists of people with decades experience from Gambro and a wide international network. This enables us to focus both on acute and chronic care settings. Our legacy and clinical experience in combination with a strong focus on simplicity and reliability, provide professionals with the right tools to improve quality of care.

We will continuously expand our offering with more products and therapy solutions developed in house as well as by our owners and partners.

One of the main shareholders in NorrDia is Tianyi Medical. Tianyi Medical is a medical device company listed in Chinese stock market, mainly focusing on development and production of consumables. The main shareholders are the father and the son, Zhimin Wu and Sam Wu.

The relationship between the two companies creates an exciting opportunity for NorrDia to realize its vision.